Lava Therapeutics NV Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Shay Capital LLC and Shay Capital Holdings LLC have reported a 9.9% beneficial ownership stake in LAVA Therapeutics NV, totaling 2,596,403 common shares.
BML Investment Partners, L.P. has reported a 7.4% beneficial ownership stake in LAVA Therapeutics N.V., holding 1,958,110 common shares.